Drug Deal Disclosure Act
Latest action · Apr 21, 2026 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 21, 2026
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Cosponsors 18
Members who signed on, in the order they did. Signatures ran from Apr 21, 2026 to Apr 27, 2026; 17 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NM | Ben Ray Luján | Original | Apr 21, 2026 |
| I-VT | Bernard Sanders | Original | Apr 21, 2026 |
| D-NV | Catherine Cortez Masto | Original | Apr 21, 2026 |
| D-MA | Elizabeth Warren | Original | Apr 21, 2026 |
| D-OR | Jeff Merkley | Original | Apr 21, 2026 |
| D-NH | Margaret Wood Hassan | Original | Apr 21, 2026 |
| D-WA | Maria Cantwell | Original | Apr 21, 2026 |
| D-AZ | Mark Kelly | Original | Apr 21, 2026 |
| D-VA | Mark R. Warner | Original | Apr 21, 2026 |
| D-HI | Mazie K. Hirono | Original | Apr 21, 2026 |
| D-CO | Michael F. Bennet | Original | Apr 21, 2026 |
| D-VT | Peter Welch | Original | Apr 21, 2026 |
| D-GA | Raphael G. Warnock | Original | Apr 21, 2026 |
| D-AZ | Ruben Gallego | Original | Apr 21, 2026 |
| D-RI | Sheldon Whitehouse | Original | Apr 21, 2026 |
| D-WI | Tammy Baldwin | Original | Apr 21, 2026 |
| D-MN | Tina Smith | Original | Apr 21, 2026 |
| D-MD | Chris Van Hollen | Apr 27, 2026 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred Apr 21, 2026 |
Actions 2
Everything that happened, newest first.
- Apr 21, 2026Introduced in Senate
- Apr 21, 2026Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| IF13281 | TrumpRx: Background and Implementation | Resource | Jul 31, 2026 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 9699 | Drug Deal Disclosure Act | Related bill | Jul 15, 2026 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.
- Short Title(s) as Introduced
- Drug Deal Disclosure Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Apr 21, 2026Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
